Clinical Trials › NCT06999434
RecruitingPhase 1
Exploring the Utility of [18F]3F4AP for Demyelination Imaging
Sponsored by Yale University
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 105
Target enrollment
1
U.S. states
May 2025
Start date
May 2030
Expected completion
Interventions / Treatments
[ 18F]3F4AP[18F]MK6240[11C]PIB
Conditions studied
MS (Multiple Sclerosis)
Where this trial is running (1 site)
Connecticut1 site
New Haven
MS centers in Connecticut
Compare treatment centers near a trial site by center type, providers and trials.
View Connecticut centersMore Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.